VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer.
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10; 35(26):2993-3001.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Renal Cell
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms
Male
Middle Aged
Proto-Oncogene Proteins c-met
Pyrazines
Triazines
Young Adult
authors with profiles
ERIC JONASCH